Meta AnalysisID 6955

百香果产品对糖尿病影响的临床前体内模型系统评价

CRD42023472406

What is the effect of Passiflora edulis products on diabetes mellitus in pre-clinical in vivo models? Context and rationale Passiflora edulis is a species native of Brazil, but also distributed in tropical and warm regio

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
6955
Evidence Id
15513
Core Evidence Id
15513
Source Meta Analysis Id
6989
Herb2 Meta Analysis Id
HBMA006989
Crd Id
CRD42023472406
Title
Influence of Passiflora edulis products on diabetes mellitus in pre-clinical in vivo models: a systematic review.
Review Question
What is the effect of Passiflora edulis products on diabetes mellitus in pre-clinical in vivo models? Context and rationale Passiflora edulis is a species native of Brazil, but also distributed in tropical and warm regions of the globe. Brazil is currently the world's largest producer of its fruit, due to the industrial production of the juice. This species, rich in phenolic compounds, has documented several pharmacological activities, such as anxiolytic, anti-inflammatory, antioxidant, antilipidemic and antiglycemic. The popular herbal use of its parts, such as leaves, bark and seeds, is widespread, mainly as an adjuvant in the control of diabetes mellitus. The species appears in official documents in Brazil, such as the National Phytotherapy Form of the Brazilian Pharmacopeia (NPFBP) and the List of Medicinal Plants of Interest to the Unified Health System (RENISUS), however, there is still no product registered with the National Health Surveillance Agency (ANVISA). In this context, seeking to understand the role of the species on diabetes mellitus (which is a chronic condition of multifactorial etiology that occurs when the pancreas no longer produces enough insulin or the body develops insulin resistance) and aiming for a potential sustainable use of the leaves and bark, which are currently considered a byproduct, it is justified to conduct a systematic review on the influence of Passiflora edulis on Diabetes Mellitus in a preclinical in vivo model.
Study Type Included
Inclusion criteria: Pre-clinical in vivo studies Exclusion criteria: 1) Clinical studies 2) Pre-clinical in vitro studies
Condition Being Studied
Participant
Animal
Inclusion criteria: 1) All animals models with Diabetes mellitus disease; 2) All species; 3) both sexes Exclusion criteria: 1) In vitro studies
Human Disease Modelled
Diabetes Mellittus
Intervention
Inclusion criteria: 1) Treatment with any parts of Passiflora edulis; 2) Timing: Not limited; 3) Frequency: Not limited; 4) Dosage: Not limited Exclusion criteria: No exclusion criterias
Comparator Control
Inclusion criteria: 1) No treatment; 2) Treated with salina; 3) Treated with vehicle; 4) Treated with antihiperglicemic drugs Exclusion criteria: No exclusion criterias
Main Outcome
Outcome Measure
Inclusion criteria: Blood glucose, glicated hemoglobin, glicogen, lipidemic profile, oxidative markers, inflammatory markers. Exclusion criteria: None.
Additional Outcome
Study Method
Keyword
MeSH headings have not been applied to this record
Contact
Luiz Ricardo Teixeira de Farias [email protected]
Organisational Affiliation
Federal University of Rio Grande do Norte
Funding Source
No funding
Other Selection Criteria
Inclusion criteria: 1) All languages; 2) All publication dates; Exclusion criteria: 1) Reviews; 2) Conference abstracts;
Final Publication
Same Topic Review
Published Protocol
Review Type
Pre-clinical animal intervention review
Language
English
Country
Brazil
Review Stage
Review Ongoing
First Submission Date
2023-10-31
Registration Date
2023-12-06
Anticipated Start Date
2022-09-26
Anticipated Completion Date
2024-08-19
Title Cn
百香果产品对糖尿病影响的临床前体内模型系统评价
Title En
Influence of Passiflora edulis products on diabetes mellitus in pre-clinical in vivo models: a systematic review.
Bilingual Status
complete